133 related articles for article (PubMed ID: 9399103)
1. Regulatory role of CD8 in major histocompatibility complex-unrestricted tumoricidal activity of mouse T cells activated with anti-CD3 monoclonal antibody.
Stewart BH; Hoskin DW
Immunol Invest; 1997; 26(5-7):601-14. PubMed ID: 9399103
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules.
Greene AL; Makrigiannis AP; Fitzpatrick L; Hoskin DW
J Interferon Cytokine Res; 1997 Dec; 17(12):727-37. PubMed ID: 9452360
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD3-activated killer T cells: interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity.
Fitzpatrick L; Makrigiannis AP; Kaiser M; Hoskin DW
J Interferon Cytokine Res; 1996 Jul; 16(7):537-46. PubMed ID: 8836920
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cytotoxic T cell lysis by anti-CD8 monoclonal antibodies: studies with CD3-targeted cytolysis of nominal antigen-negative targets.
Quinones RR; Segal DM; Henkart P; Perez P; Gress RE
J Immunol; 1989 Apr; 142(7):2200-6. PubMed ID: 2466891
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
Patel SS; Thiele DL; Lipsky PE
J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
Thiele DL; Patel SS; Lipsky PE
J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209
[TBL] [Abstract][Full Text] [Related]
11. Expression and utilization of chymotrypsin-like but not trypsin-like serine protease enzymes by nonspecific T killer cells activated by anti-CD3 monoclonal antibody.
Kaiser M; Hoskin DW
Cell Immunol; 1992 Apr; 141(1):84-98. PubMed ID: 1532539
[TBL] [Abstract][Full Text] [Related]
12. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
13. IL-4 regulation of a protein kinase C independent pathway for the generation of alpha CD3-induced activated killer cells.
Ting CC; Hargrove ME
Cell Immunol; 1992 Mar; 140(1):130-44. PubMed ID: 1531452
[TBL] [Abstract][Full Text] [Related]
14. Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody.
Zhao C; Morgan M; Haeryfar SM; Blay J; Hoskin DW
Cancer Immunol Immunother; 2003 Mar; 52(3):185-93. PubMed ID: 12649748
[TBL] [Abstract][Full Text] [Related]
15. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
Zhu HG; Klein-Franke A; Anderer FA
Anticancer Res; 1994; 14(3A):953-61. PubMed ID: 8074498
[TBL] [Abstract][Full Text] [Related]
16. 2-Chloroadenosine inhibits the MHC-unrestricted cytolytic activity of anti-CD3-activated killer cells: evidence for the involvement of a non-A1/A2 cell-surface adenosine receptor.
Hoskin DW; Reynolds T; Blay J
Cell Immunol; 1994 Nov; 159(1):85-93. PubMed ID: 7954843
[TBL] [Abstract][Full Text] [Related]
17. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
18. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells.
Baume DM; Caligiuri MA; Manley TJ; Daley JF; Ritz J
Cell Immunol; 1990 Dec; 131(2):352-65. PubMed ID: 2122925
[TBL] [Abstract][Full Text] [Related]
20. In vivo antitumor activity of anti-CD3-induced activated killer cells.
Yun YS; Hargrove ME; Ting CC
Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
